168 related articles for article (PubMed ID: 1653606)
1. Identifying the molecular switches that determine whether (Rp)-cAMPS functions as an antagonist or an agonist in the activation of cAMP-dependent protein kinase I.
Dostmann WR; Taylor SS
Biochemistry; 1991 Sep; 30(35):8710-6. PubMed ID: 1653606
[TBL] [Abstract][Full Text] [Related]
2. Role of MgATP in the activation and reassociation of cAMP-dependent protein kinase I: consequences of replacing the essential arginine in cAMP binding site A.
Neitzel JJ; Dostmann WR; Taylor SS
Biochemistry; 1991 Jan; 30(3):733-9. PubMed ID: 1846304
[TBL] [Abstract][Full Text] [Related]
3. A mechanistic and kinetic analysis of the interactions of the diastereoisomers of adenosine 3',5'-(cyclic)phosphorothioate with purified cyclic AMP-dependent protein kinase.
Rothermel JD; Parker Botelho LH
Biochem J; 1988 May; 251(3):757-62. PubMed ID: 2843164
[TBL] [Abstract][Full Text] [Related]
4. Effects of the specific cAMP antagonist, (Rp)-adenosine cyclic 3',5'-phosphorothioate, on the cAMP-dependent protein kinase-induced activity of hepatic glycogen phosphorylase and glycogen synthase.
Rothermel JD; Perillo NL; Marks JS; Botelho LH
J Biol Chem; 1984 Dec; 259(24):15294-300. PubMed ID: 6096366
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory action of certain cyclophosphate derivatives of cAMP on cAMP-dependent protein kinases.
de Wit RJ; Hekstra D; Jastorff B; Stec WJ; Baraniak J; Van Driel R; Van Haastert PJ
Eur J Biochem; 1984 Jul; 142(2):255-60. PubMed ID: 6086345
[TBL] [Abstract][Full Text] [Related]
6. A kinetic study of interactions of (Rp)- and (Sp)-adenosine cyclic 3',5'-phosphorothioates with type II bovine cardiac muscle adenosine cyclic 3',5'-phosphate dependent protein kinase.
O'Brian CA; Roczniak SO; Bramson HN; Baraniak J; Stec WJ; Kaiser ET
Biochemistry; 1982 Aug; 21(18):4371-6. PubMed ID: 6289880
[TBL] [Abstract][Full Text] [Related]
7. (RP)-cAMPS inhibits the cAMP-dependent protein kinase by blocking the cAMP-induced conformational transition.
Dostmann WR
FEBS Lett; 1995 Nov; 375(3):231-4. PubMed ID: 7498506
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of cyclic AMP-dependent protein kinase-induced changes in the kinetic properties of hepatic pyruvate kinase by the specific cyclic AMP antagonist, the (Rp)-diastereomer of adenosine cyclic 3',5'-phosphorothioate.
Dragland-Meserve CJ; Rothermel JD; Houlihan MJ; Botelho LH
J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(4):371-82. PubMed ID: 2993387
[TBL] [Abstract][Full Text] [Related]
9. Crystal structures of RIalpha subunit of cyclic adenosine 5'-monophosphate (cAMP)-dependent protein kinase complexed with (Rp)-adenosine 3',5'-cyclic monophosphothioate and (Sp)-adenosine 3',5'-cyclic monophosphothioate, the phosphothioate analogues of cAMP.
Wu J; Jones JM; Nguyen-Huu X; Ten Eyck LF; Taylor SS
Biochemistry; 2004 Jun; 43(21):6620-9. PubMed ID: 15157095
[TBL] [Abstract][Full Text] [Related]
10. A study of the mechanism of glucagon-induced protein phosphorylation in isolated rat hepatocytes using (Sp)-cAMPS and (Rp)-cAMPS, the stimulatory and inhibitory diastereomers of adenosine cyclic 3',5'-phosphorothioate.
Connelly PA; Botelho LH; Sisk RB; Garrison JC
J Biol Chem; 1987 Mar; 262(9):4324-32. PubMed ID: 3031072
[TBL] [Abstract][Full Text] [Related]
11. Blockade of granulosa cell differentiation by an antagonistic analog of adenosine 3',5'-cyclic monophosphate (cAMP): central but non-exclusive intermediary role of cAMP in follicle-stimulating hormone action.
Adashi EY; Resnick CE; Jastorff B
Mol Cell Endocrinol; 1990 Jul; 72(1):1-11. PubMed ID: 2177013
[TBL] [Abstract][Full Text] [Related]
12. Dissecting the domain structure of the regulatory subunit of cAMP-dependent protein kinase I and elucidating the role of MgATP.
Ringheim GE; Taylor SS
J Biol Chem; 1990 Mar; 265(9):4800-8. PubMed ID: 2156855
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of choriogonadotropin-activated steroidogenesis in cultured Leydig tumor cells by the Rp diastereoisomer of adenosine 3',5'-cyclic phosphorothioate.
Pereira ME; Segaloff DL; Ascoli M; Eckstein F
J Biol Chem; 1987 May; 262(13):6093-100. PubMed ID: 2437113
[TBL] [Abstract][Full Text] [Related]
14. Novel (Rp)-cAMPS analogs as tools for inhibition of cAMP-kinase in cell culture. Basal cAMP-kinase activity modulates interleukin-1 beta action.
Gjertsen BT; Mellgren G; Otten A; Maronde E; Genieser HG; Jastorff B; Vintermyr OK; McKnight GS; Døskeland SO
J Biol Chem; 1995 Sep; 270(35):20599-607. PubMed ID: 7657638
[TBL] [Abstract][Full Text] [Related]
15. Rp diastereomeric analogs of cAMP inhibit both cAMP- and cGMP-induced dilation of hamster mesenteric small arteries.
Jackson WF
Pharmacology; 1996 Apr; 52(4):226-34. PubMed ID: 8841085
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of glycogenolysis in isolated rat hepatocytes by the Rp diastereomer of adenosine cyclic 3',5'-phosphorothioate.
Rothermel JD; Stec WJ; Baraniak J; Jastorff B; Botelho LH
J Biol Chem; 1983 Oct; 258(20):12125-8. PubMed ID: 6313639
[TBL] [Abstract][Full Text] [Related]
17. Competitive cAMP antagonists for cAMP-receptor proteins.
Van Haastert PJ; Van Driel R; Jastorff B; Baraniak J; Stec WJ; De Wit RJ
J Biol Chem; 1984 Aug; 259(16):10020-4. PubMed ID: 6088478
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of hepatic gluconeogenesis by the Rp-diastereomer of adenosine cyclic 3',5'-phosphorothioate.
Dragland-Meserve CJ; Olivieri MC; Botelho LH
Biochem J; 1986 Jul; 237(2):463-8. PubMed ID: 3026318
[TBL] [Abstract][Full Text] [Related]
19. Modulation of cyclic AMP action in the dog thyroid by its agonist and antagonist Sp- and Rp-adenosine 3',5'-monophosphorothioate.
Erneux C; Van Sande J; Jastorff B; Dumont JE
Biochem J; 1986 Feb; 234(1):193-7. PubMed ID: 3010952
[TBL] [Abstract][Full Text] [Related]
20. Active site mutations define the pathway for the cooperative activation of cAMP-dependent protein kinase.
Herberg FW; Taylor SS; Dostmann WR
Biochemistry; 1996 Mar; 35(9):2934-42. PubMed ID: 8608131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
